Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Susanna Schraen‐Maschke"'
Autor:
Sylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, Jean-Sébastien Vidal, Constance Delaby, Christophe Hirtz, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Olivier Hanon, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Publikováno v:
Molecular Neurodegeneration, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Current AT(N) stratification for Alzheimer’s disease (AD) accounts for complex combinations of amyloid (A), tau proteinopathy (T) and neurodegeneration (N) signatures. Understanding the transition between these different stages
Externí odkaz:
https://doaj.org/article/c860af25033746cb82e1ae7cdbcb2d80
Autor:
Constance Delaby, Olivier Bousiges, Damien Bouvier, Catherine Fillée, Anthony Fourier, Etienne Mondésert, Nicolas Nezry, Souheil Omar, Isabelle Quadrio, Benoit Rucheton, Susanna Schraen-Maschke, Vincent van Pesch, Stéphanie Vicca, Sylvain Lehmann, Aurelie Bedel
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
Neurological biomarkers are particularly valuable to clinicians as they can be used for diagnosis, prognosis, or response to treatment. This field of neurology has evolved considerably in recent years with the improvement of analytical methods, allow
Externí odkaz:
https://doaj.org/article/b931b35796fd4807bbef259aa2ce127f
Autor:
Emmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, Audrey Gabelle, Sylvain Lehmann, Florence Pasquier, Stéphanie Bombois, Luc Buée, Bernadette Allinquant, Susanna Schraen-Maschke, Christiane Baret, Anne-Sophie Rigaud, Olivier Hanon, Jacques Epelbaum
Publikováno v:
Frontiers in Aging Neuroscience, Vol 11 (2019)
Externí odkaz:
https://doaj.org/article/c28a93e9496345a0a90227c11cc8cedd
Autor:
Emmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, Audrey Gabelle, Sylvain Lehmann, Florence Pasquier, Stéphanie Bombois, Luc Buée, Bernadette Allinquant, Susanna Schraen-Maschke, Christiane Baret, Anne-Sophie Rigaud, Olivier Hanon, Jacques Epelbaum
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
A combination of low cerebrospinal fluid (CSF) Amyloid β1–42 (Aβ1–42) and high Total-Tau (T-Tau) and Phosphorylated-Tau (P-Tau) occurs at a prodromal stage of Alzheimer’s disease (AD) and recent findings suggest that network abnormalities and
Externí odkaz:
https://doaj.org/article/c2546e5c9f8a4a99a9fe2b92399fd965
Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology
Autor:
Karim Belarbi, Sylvie Burnouf, Francisco-Jose Fernandez-Gomez, Cyril Laurent, Sophie Lestavel, Martin Figeac, Audrey Sultan, Laetitia Troquier, Antoine Leboucher, Raphaëlle Caillierez, Marie-Eve Grosjean, Dominique Demeyer, Hélène Obriot, Ingrid Brion, Bérangère Barbot, Marie-Christine Galas, Bart Staels, Sandrine Humez, Nicolas Sergeant, Susanna Schraen-Maschke, Anne Muhr-Tailleux, Malika Hamdane, Luc Buée, David Blum
Publikováno v:
Neurobiology of Disease, Vol 43, Iss 2, Pp 486-494 (2011)
Tau pathology is encountered in many neurodegenerative disorders known as tauopathies, including Alzheimer's disease. Physical activity is a lifestyle factor affecting processes crucial for memory and synaptic plasticity. Whether long-term voluntary
Externí odkaz:
https://doaj.org/article/474624de82d042e7851d6576a260bf6a
Publikováno v:
Neurobiology of Disease, Vol 15, Iss 3, Pp 449-460 (2004)
Tau is a microtubule-associated protein mainly expressed in neurons of central nervous system, which is crucial in the maintenance of these cells. It has a central role in the polymerization and stabilization of microtubules and in the traffic of org
Externí odkaz:
https://doaj.org/article/263db083f2524dc49100ddf2d97c7e8b
Autor:
Jean-Charles Lambert, Jean Dallongeville, Kathryn A Ellis, Susanna Schraen-Maschke, James Lui, Simon Laws, Julie Dumont, Florence Richard, Dominique Cottel, Claudine Berr, David Ames, Colin L Masters, Christopher C Rowe, Cassandra Szoeke, Christophe Tzourio, Jean-François Dartigues, Luc Buée, Ralph Martins, Philippe Amouyel
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e18536 (2011)
BackgroundAß peptides are often considered as catabolic by-products of the amyloid ß protein precursor (APP), with unknown physiological functions. However, several biological properties have been tentatively attributed to these peptides, including
Externí odkaz:
https://doaj.org/article/6f0cab3571dc40e7a4138ded5e45958e
Autor:
Catherine Féart, Catherine Helmer, Hervé Fleury, Yannick Béjot, Karen Ritchie, Philippe Amouyel, Susanna Schraen-Maschke, Luc Buée, Jean-Charles Lambert, Luc Letenneur, Jean-François Dartigues
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e29480 (2011)
ObjectiveHerpes simplex virus (HSV) reactivation has been identified as a possible risk factor for Alzheimer's disease (AD) and plasma amyloid-beta (Aβ) levels might be considered as possible biomarkers of the risk of AD. The aim of our study was to
Externí odkaz:
https://doaj.org/article/e76c835c35224b4d8c631e42de6b8748
Autor:
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, Constance Delaby, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Olivier Hanon
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 94:411-419
ObjectivesPlasma P-tau181 is an increasingly established diagnostic marker for Alzheimer’s disease (AD). Further validation in prospective cohorts is still needed, as well as the study of confounding factors that could influence its blood level.Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d803ea983f64bba99eb7d36b356a49
https://doi.org/10.1136/jnnp-2022-330540
https://doi.org/10.1136/jnnp-2022-330540
Autor:
Robert Jr Laforce, Caroline Dallaire-Théroux, Annie M. Racine, Gersham Dent, Cristian Salinas-Valenzuela, Elizabeth Poulin, Anne-Marie Cayer, Daphnée Bédard-Tremblay, Thierry Rouleau-Bonenfant, Frédéric St-Onge, Susanna Schraen-Maschke, Jean-Mathieu Beauregard, Nicolas Sergeant, Jack Puymirat
Publikováno v:
Journal of Neurology. 269:3579-3587
Objective To investigate Tau pathology using multimodal biomarkers of neurodegeneration and neurocognition in participants with myotonic dystrophy type 1 (DM1). Methods We recruited twelve participants with DM1 and, for comparison, two participants w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b838a1fafaf498ef57885a6bad547b8d
https://doi.org/10.1007/s00415-022-10970-x
https://doi.org/10.1007/s00415-022-10970-x